Search research articles
Contact Us
Filters
Showing results (661-670 of 1,058) with videos related to
Page
of 106
Sort By:
The Journal of Biological Chemistry
|
August 2, 2013
Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies
Steven E Justiniano, Saranya Elavazhagan, Kavin Fatehchand, et al.
Blood Advances
|
October 26, 2022
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
Tzung-Huei Lai, Hatice Gulcin Ozer, Pierluigi Gasparini, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma
Jonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Cancers
|
January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/Deletion
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Leukemia & Lymphoma
|
March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphoma
Bonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
Preventing Chronic Disease
|
December 17, 2005
The Prevention Research Centers Healthy Aging Research Network
Jason E Lang, Lynda Anderson, James LoGerfo, et al.
Journal of Geriatric Oncology
|
July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant
Ashley E Rosko, Ying Huang, Don M Benson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 1, 2009
Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing
Chee Guan Koh, Xulang Zhang, Shujun Liu, et al.
Leukemia
|
May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
K A Blum, A S Ruppert, J A Woyach, et al.
Blood Advances
|
October 18, 2023
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
Samantha M Teierle, Ying Huang, Adam S Kittai, et al.
Page
of 106
Search research articles
Search
Showing results (661-670 of 1,058) with videos related to
Sort By:
Page
of 106
The Journal of Biological Chemistry
|
August 2, 2013
Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies
Steven E Justiniano, Saranya Elavazhagan, Kavin Fatehchand, et al.
Blood Advances
|
October 26, 2022
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
Tzung-Huei Lai, Hatice Gulcin Ozer, Pierluigi Gasparini, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma
Jonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Cancers
|
January 8, 2023
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/Deletion
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, et al.
Leukemia & Lymphoma
|
March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphoma
Bonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
Preventing Chronic Disease
|
December 17, 2005
The Prevention Research Centers Healthy Aging Research Network
Jason E Lang, Lynda Anderson, James LoGerfo, et al.
Journal of Geriatric Oncology
|
July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant
Ashley E Rosko, Ying Huang, Don M Benson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 1, 2009
Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing
Chee Guan Koh, Xulang Zhang, Shujun Liu, et al.
Leukemia
|
May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
K A Blum, A S Ruppert, J A Woyach, et al.
Blood Advances
|
October 18, 2023
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
Samantha M Teierle, Ying Huang, Adam S Kittai, et al.
Page
of 106